MATTHEW R WOLFF, MD
Osteopathic Medicine at Beltline Hwy, Madison, WI
License number
Wisconsin 33845
Category
Osteopathic Medicine
Type
Interventional Cardiology
Address
Address
2601 W Beltline Hwy, Madison, WI 53713
Phone
(608) 417-2100
Organization information
See more information about MATTHEW R WOLFF at bizstanding.comMeriter Wisconsin Heart - Matthew R Wolff MD
2601 W Beltline Hwy STE 300, Madison, WI 53713
Categories:
Cardiology Physicians & Surgeons, Physicians & Surgeons
Site:
Phone:
(608) 417-2100 (Phone)
Specialties:
Heart Conditions, Research
Products:
Cardiac & Vascular Specialists, Cardiology, Comprehensive Cardiac and Vascular Medicine., ...
Certifications:
Icael
Open Hours:
Mon-Fri Weekdays
Additional:
Accredited Echo. Nuclear and Vascular Labs.
Uw Health - Matthew R Wolff MD
202 S Park St #3, Madison, WI 53715
Categories:
Cardiology Physicians & Surgeons
Phone:
(608) 417-5970 (Phone)
Professional information
Dr. Matthew R Wolff, Madison WI - MD (Doctor of Medicine)
Specialties:
Cardiology, Interventional Cardiology
Address:
Meriter Wisconsin Heart
2601 W Beltline Hwy, Madison 53713
(608) 417-2100 (Phone), (608) 417-2101 (Fax)
2601 W Beltline Hwy, Madison 53713
(608) 417-2100 (Phone), (608) 417-2101 (Fax)
Certifications:
Cardiology, Cardiovascular Disease, 2006, Internal Medicine, Interventional Cardiology
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
Meriter Wisconsin Heart
2601 W Beltline Hwy, Madison 53713
University of Wisconsin Hospitals And Clinics
600 Highland Ave, Madison 53792
Monroe Clinic
515 22Nd Ave, Monroe 53566
Meriter Hospital
202 South Park St, Madison 53715
Saint Clare Hospital Health Services
707 14Th St, Baraboo 53913
Reedsburg Area Medical Center
2000 North Dewey Ave, Reedsburg 53959
2601 W Beltline Hwy, Madison 53713
University of Wisconsin Hospitals And Clinics
600 Highland Ave, Madison 53792
Monroe Clinic
515 22Nd Ave, Monroe 53566
Meriter Hospital
202 South Park St, Madison 53715
Saint Clare Hospital Health Services
707 14Th St, Baraboo 53913
Reedsburg Area Medical Center
2000 North Dewey Ave, Reedsburg 53959
Philosophy:
I ensure my patients understand all aspects of their condition, empowering them to be an active participant in their medical care. I view myself as my patient?s employee, working hard to earn their respect by providing information, advice and the most advanced treatment options available. It is important to me that my patients have 100% confidence in the decisions we have made together. www.meriter.com/wolff
Education:
Medical School
Johns Hopkins University School Of Medicine
Graduated: 1986
Johns Hopkins University Hospital
Graduated: 1988
Graduated: 1992
College Of Wooster
Graduated: 1982
Johns Hopkins University School Of Medicine
Graduated: 1986
Johns Hopkins University Hospital
Graduated: 1988
Graduated: 1992
College Of Wooster
Graduated: 1982
Chief, Division Of Cardiovascular Medicine At University Of Wisconsin
Position:
Associate Chief for Research and Education at Meriter Wisconsin Heart
Location:
Madison, Wisconsin Area
Industry:
Medical Practice
Work:
Meriter Wisconsin Heart
since Jul 2011
-
Associate Chief for Research and Education
University of Wisconsin
Jun 2005 - Feb 2011
-
Chief, Division of Cardiovascular Medicine
Vascular Stent Or Graft Coated Or Impregnated With Protein Tyrosine Kinase Inhibitors And Method Of Using Same
US Patent:
2004004, Mar 4, 2004
Filed:
Oct 25, 2002
Appl. No.:
10/280576
Inventors:
Matthew Wolff - Middleton WI, US
Scott Stoker - Evansville WI, US
Michael Griffin - San Diego CA, US
Scott Stoker - Evansville WI, US
Michael Griffin - San Diego CA, US
International Classification:
A61F002/06
US Classification:
623/001460
Abstract:
Disclosed is a device, such as a cardiovascular stent, autologous venous/arterial graft, prosthetic venous/arterial graft, vascular catheter, or vascular shunt, for stenting a blood vessel, The device has coated thereon, adsorbed thereto, impregnated therein, or covalently or ionically bonded thereto an amount of a protein tyrosine kinase inhibitor. The protein tyrosine kinase inhibitor inhibits proliferation of vascular smooth muscle cells in an area within a blood vessel immediately adjacent to and/or proximal to the device, while simultaneously not inhibiting the proliferation of vascular intimal cells. A corresponding method of using the device to stent blood vessels is also disclosed.
Process For Delivering Nucleic Acids To Cardiac Tissue
US Patent:
6867196, Mar 15, 2005
Filed:
Jun 11, 1999
Appl. No.:
09/330909
Inventors:
Jon A. Wolff - Madison WI, US
Hans Herweijer - Madison WI, US
Larry F. Whitesell - Lodi WI, US
Matthew R. Wolff - Middleton WI, US
Sean D. Monahan - Madison WI, US
Paul M. Slattum - Madison WI, US
James E. Hagstrom - Middleton WI, US
Vladimir G. Budker - Middleton WI, US
David B. Rozema - Madison WI, US
Hans Herweijer - Madison WI, US
Larry F. Whitesell - Lodi WI, US
Matthew R. Wolff - Middleton WI, US
Sean D. Monahan - Madison WI, US
Paul M. Slattum - Madison WI, US
James E. Hagstrom - Middleton WI, US
Vladimir G. Budker - Middleton WI, US
David B. Rozema - Madison WI, US
Assignee:
Mirus Bio Corporation - Madison WI
International Classification:
A61K031/70, A01N043/04
US Classification:
514 44
Abstract:
A process for delivering a nucleic acid to a cardiac tissue cell in a mammal is described, comprising introducing a composition consisting of a nucleic acid to a blood vessel, which subsequently delivers the nucleic acid to the cardiac tissue cell. The nucleic acid can be DNA or RNA or plasmid DNA or viral. This process is for purposes of gene therapy, and research.
Process For Delivering Nucleic Acids To Cardiac Tissue
US Patent:
2005022, Oct 6, 2005
Filed:
May 25, 2005
Appl. No.:
11/137317
Inventors:
Hans Herweijer - Madison WI, US
Jon Wolff - Madison WI, US
Matthew Wolff - Middleton WI, US
Larry Whitesell - Lodi WI, US
Jon Wolff - Madison WI, US
Matthew Wolff - Middleton WI, US
Larry Whitesell - Lodi WI, US
International Classification:
A61K048/00, A61M031/00
US Classification:
514044000, 604500000
Abstract:
A process for delivering a nucleic acid to a cardiac tissue cell in a mammal is described, comprising introducing a composition consisting of a nucleic acid to a blood vessel, which subsequently delivers the nucleic acid to the cardiac tissue cell. The nucleic acid can be DNA or RNA or plasmid DNA or viral. This process is for purposes of gene therapy, and research.